Two-part cyanoacrylate curable adhesive system

Patent metadata

Field	Value
Publication number	US-12030971-B2
Application number	US-202117156888-A
Country	US
Kind code	B2
Filing date	Jan 25, 2021
Priority date	Aug 13, 2018
Publication date	Jul 9, 2024
Grant date	Jul 9, 2024

Abstract

Two-part cyanoacrylate/cationically curable adhesive systems are provided.

First claim

The invention claimed is:

1. A two-part curable composition comprising:
a. a first part comprising a cyanoacrylate component, a cationic catalyst, and a plurality of polyolefin fibres having an average length of from about 400 μm to about 1000 μm and an average diameter of more than about 5 μm and less than about 25 μm, which are present in an amount of from about 0.5 wt % to about 3.5 wt % based on the total weight of the first part of the composition;
b. a second part comprising a cationic curable component, and an initiator component;
wherein when mixed together the cationic catalyst initiates cure of the cationic curable component.

2. The composition of claim 1 , wherein the first part has an initial viscosity from about 6,000 to about 16,000 m·Pas, when measured at 25° C.; and wherein the first part has a viscosity of from about 12,000 m·Pas to about 48,000 m·Pas, when measured at 25° C., after aging for 72 hours at 82° C.

3. The composition of claim 1 , wherein the polyolefin fibres are high density polyethylene.

4. The composition of claim 1 , wherein the viscosity of the first part when measured at 25° C., after ageing for 72 hours at 82° C., is less than about three times the initial viscosity of the first part when measured at 25° C.

5. The composition of claim 1 , wherein the cyanoacrylate component comprises H 2 C═C(CN)—COOR, wherein R is selected from alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups.

6. The composition of claim 1 , wherein the cationic catalyst comprises salts of lithium and non-nucleophilic acid; or salts of Group II metals of the Periodic Table and non-nucleophilic acids.

7. The composition of claim 6 , wherein the non-nucleophilic acid has a pH of less than 1.0 when measured as a 10% by weight solution in water.

8. The composition of claim 6 , wherein the non-nucleophilic acid is a member selected from the group consisting of fluoroboric acids, fluoroarsenic acids, fluoroantimonic acids, and fluorophosphoric acids.

9. The composition of claim 1 , wherein the cationic catalyst is a member selected from the group consisting of lithium tetrafluoroborate, calcium di-tetrafluoroborate, magnesium di-tetrafluoroborate, lithium hexafluorophosphate, calcium di-hexafluorophosphate, magnesium di-hexafluorophosphate, lithium hexafluoroantimonate, lithium hexafluoroarsenate, lanthanide triflate salts, aryl iodonium salts, aryl sulfonium salts, lanthanum triflate, ytterbium triflate, trimethoxyboroxine, trimethoxyboroxine-aluminum acetyl acetonate, amine-boron trihalide complexes, quaternary ammonium salts, quaternary phosphonium salts, tri-aryl sulfonium salts, di-aryl iodonium salts, diazonium salts, trialkoxyboroxine curing agents, and combinations thereof.

10. The composition of claim 1 , wherein the cationic curable component is selected from an epoxy component, an episulfide component, an oxetane component, a vinyl ether component and combinations thereof.

11. The composition of claim 1 , wherein the cationic curable component is an epoxy component selected from the group consisting of cycloaliphatic epoxy, aromatic epoxy, aliphatic epoxy and hydrogenated aromatic epoxy.

12. The composition of claim 11 , wherein the epoxy component comprises a member selected from the group consisting of bisphenol-A diglycidyl ether, hydrogenated bisphenol-A diglycidyl ether, bisphenol-F diglycidyl ether, hydrogenated bisphenol-F diglycidyl ether, bisphenol-E diglycidyl ether, hydrogenated bisphenol-E diglycidyl ether, bisphenol-S diglycidyl ether, hydrogenated bisphenol-S diglycidyl ether, biphenyl diglycidyl ether, and hydrogenated biphenyl diglycidyl ether.

13. The composition of claim 1 , wherein the first part is housed in a first chamber of a dual chamber syringe and the second part is housed in a second chamber of the dual chamber syringe.

14. The composition of claim 1 , wherein the first part further comprises phosphoric acid.

15. The composition of claim 1 , wherein the second part further comprises at least one of a plasticizer, a filler and a toughener.

16. The composition of claim 15 , wherein the toughener is a member selected from the group consisting of (1)(a) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (2)(b) dipolymers of ethylene and methyl acrylate, (3) combinations of (a) and (b), (4) vinylidene chloride-acrylonitrile copolymers, (5) vinyl chloride/vinyl acetate copolymer, (6) copolymers of polyethylene and polyvinyl acetate, and combinations thereof.

17. The composition of claim 1 , wherein the first part and the second part are present in a ratio of about 1:1 by volume.

18. The composition of claim 1 , wherein the first part and the second part are each housed in a separate chamber of a dual chambered container.

19. A two-part curable composition comprising:
a. a first part comprising a cyanoacrylate component, a cationic catalyst, and a plurality of polyolefin fibres;
b. a second art comprising a cationic curable component, and an initiator component;
c. core-shell rubber particles comprising acrylonitrile butadiene-styrene copolymer and/or methyl methacrylate butadiene styrene copolymer, wherein the core-shell rubber particles are present in an amount of from about 0.1 to about 5 weight percent, in the first part of the composition, based on the total weight of the first part of the composition;
wherein when mixed together the cationic catalyst initiates cure of the cationic curable component.

20. The composition of claim 19 , wherein the polyolefin fibres have an average length of from about 400 μm to about 1000 μm.

21. The composition of claim 19 , wherein the polyolefin fibres have an average diameter of more than about 5 μm and less than about 25 μm.

22. The composition of claim 19 , wherein the polyolefin fibres are present in an amount of from about 0.1 wt % to about 5 wt % based on the total weight of the first part of the composition.

23. A two-part curable composition comprising:
a. a first part comprising a cyanoacrylate component, a cationic catalyst, and a plurality of polyolefin fibres;
b. a second part comprising a cationic curable component, and an initiator component;
c. core-shell rubber particles comprising acrylonitrile butadiene-styrene copolymer and/or methyl methacrylate butadiene styrene copolymer, wherein the core-shell rubber particles have an average particle size of from about 50 μm to about 300 μm;
wherein when mixed together the cationic catalyst initiates cure of the cationic curable component.

Assignees

• Henkel IP & Holding GmbH
• Henkel Ag & Co Kgaa

Inventors

• Mooney Aine
• Shah Jayesh P
• Tathe Dipak

Classifications

• C09J133/14

  of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen · CPC title

• C09J4/00 Primary

  Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond {; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16} · CPC title

• C08L51/04

  grafted on to rubbers · CPC title

• C08K7/02

  Fibres or whiskers · CPC title

• C08F2/38

  Polymerisation using regulators, e.g. chain terminating agents {, e.g. telomerisation} · CPC title